GlassScriptPhysician profile
Jacqueline K Souza
NPI 1770636979
$1,253.41
in general payments reported to CMS, 2019-2025
20 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.54 · 2020: $34.78 · 2021: $162 · 2022: $205 · 2023: $351 · 2024: $295 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $397.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $177.86 | 2021-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $149.48 | 2021-2024 | |
| Cranial Technologies, INC | $127.21 | 2019-2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $49.79 | 2024 | Ycanth |
| Glaxosmithkline, LLC. | $38.18 | 2025 | Bexsero, Pediarix, Rotarix |
| Genentech USA, INC. | $35.08 | 2020-2021 | |
| Sobi, INC | $28.61 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $26.92 | 2025 | Neffy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.10 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $22.17 | 2024 | Rexulti |
| Cognoa, INC. | $22.13 | 2021 | |
| Exact Sciences Corporation | $21.81 | 2024 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $21.08 | 2021 | |
| Biomarin Pharmaceutical INC. | $20.57 | 2024 | Voxzogo 1.2mg |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.16 | 2019 | |
| Avanir Pharmaceuticals, INC. | $20.06 | 2019 | |
| Seqirus USA INC | $18.16 | 2024 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $16.43 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Souza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.